Steenbrass Pharmaceuticals Private Limited

Steenbrass Pharmaceuticals Private Limited - chemicals in Mumbai, Maharashtra, India. Directors, charges & compliance details.
CIN U74900MH2012PTC236693 Incorporated 11 October 2012 ROC Mumbai HQ Mumbai, Maharashtra, India
Struck Off Private Limited Company chemicals
Data last updated
Revenue · FY 2015
₹40.17 Lakh
▼ 12% YoY
Net loss · FY 2015
₹2.23 Lakh
Net margin -5.6%
EBITDA · FY 2015
₹2.7 Lakh
EBITDA margin 6.7%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
14 yrs
Est. 2012
Directors on board
4
As per MCA filings
GST registrations
1
None active

About Steenbrass Pharmaceuticals Private Limited

Data last updated:

Steenbrass Pharmaceuticals Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 11 October 2012.

The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U74900MH2012PTC236693. The company has 1 GST registration on record, which is no longer active.

The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was led by directors including Ajay Kumar Kamala Prasad Tiwari and Deepchand Ramkhilavan Dubey.

Its last annual general meeting (AGM) was held on 30 September 2015, and its latest financial statements are for the year ended 31 March 2015. The registered office was at Narayan Bldg 1st Flr Flat No.6 Parsiwadi Road Ghatkopar (W), Mumbai, Maharashtra, India – 400086.

As per the financials filed for FY 2015, the company reported a revenue of ₹40.17 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net loss of ₹2.23 Lakh (net margin -5.6%) and EBITDA of ₹2.7 Lakh (EBITDA margin 6.7%).

Court records list 1 case involving the company; 1 case is pending.

Company Details of Steenbrass Pharmaceuticals Private Limited
CIN U74900MH2012PTC236693
Registration Number 236693
Incorporation Date 11 October 2012
ROC Mumbai
Listing Status Unlisted
Company Status Struck Off
Date of Last AGM 30 September 2015
Date of Balance Sheet 31 March 2015
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Narayan Bldg 1st Flr Flat No.6 Parsiwadi Road Ghatkopar (W), Mumbai, Maharashtra, India – 400086
  • Industry
    Chemicals, Medicinal Chemical & Botanical Products, Chemical Products, Pharmaceuticals
Comprehensive company report
Steenbrass Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Steenbrass Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Steenbrass Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Steenbrass Pharmaceuticals Private Limited

The main business activity of Steenbrass Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Steenbrass Pharmaceuticals Private Limited FY 2015 filings available

Steenbrass Pharmaceuticals Private Limited reported revenue of ₹40.17 Lakh (down 12% YoY) for FY 2015.

Revenue · FY 2015
₹40.17 Lakh ▼ 12%
Net loss · FY 2015
₹2.23 Lakh margin -5.6%
EBITDA · FY 2015
₹2.7 Lakh margin 6.7%

Compounded Annual Growth Rate (CAGR) of Steenbrass Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▼ 12%
EBITDA CAGR growth
1 year
▲ 2%

Revenue fell 12% in the latest year. EBITDA rose 2% in the latest year. All are worked out from the filed statements.

Financial Statement Summary of Steenbrass Pharmaceuticals Private Limited

MetricsFY 2014-15
Profit and Loss Statement
Revenue from Operations••••
Other Income••••
Total Revenue••••
Cost of Materials Consumed••••
Employee Benefit Expense••••
Finance Costs••••
Depreciation and Amortisation••••
Other Expenses••••
Total Expenses••••
EBITDA₹2.7 Lakh
Profit Before Tax••••
Tax Expense••••
Net Profit (PAT)-₹2.23 Lakh
Balance Sheet
Share Capital••••
Reserves and Surplus••••
Net Worth (Total Equity)••••
Long-term Borrowings••••
Short-term Borrowings••••
Trade Payables••••
Total Liabilities••••
Fixed Assets••••
Investments••••
Inventories••••
Trade Receivables••••
Cash and Bank Balance••••
Total Assets••••

Financial Ratios of Steenbrass Pharmaceuticals Private Limited

MetricsFY 2014-15
Profitability
EBITDA Margin6.7%
Net Profit Margin-5.6%
Return on Equity (ROE)••••
Return on Capital Employed (ROCE)••••
Return on Assets (ROA)••••
Liquidity and Debt
Current Ratio••••
Quick Ratio••••
Debt-to-Equity Ratio••••
Interest Coverage Ratio••••
Efficiency and Growth
Asset Turnover••••
Receivable Days••••
Payable Days••••
Inventory Days••••
Revenue Growth••••
Net Profit Growth••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Steenbrass Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Steenbrass Pharmaceuticals Private Limited

Steenbrass Pharmaceuticals has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Ajay Kumar Kamala Prasad TiwariDirector25 Oct 201213 Years 11 MonthsAs last reported
Deepchand Ramkhilavan DubeyDirector11 Oct 201214 Years 0 MonthsAs last reported
Suryaji Arjun RaneDirector25 Oct 201213 Years 11 MonthsAs last reported
Shailesh Sadanand ShuklaDirector11 Oct 201214 Years 0 MonthsAs last reported

Peer Comparison of Steenbrass Pharmaceuticals Private Limited

Steenbrass Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Lovyaam Pharma Private Limited₹40.27 Lakh (FY 2025)••••••••6.0%••••Ahmedabad, Gujarat, India
Ashmai and Associates Private Limited₹40.23 Lakh (FY 2025)••••••••-8.0%••••New Delhi, Delhi, India
Ransaw Remedies Private Limited₹40.22 Lakh (FY 2024)••••••••17.0%••••Thane, Maharashtra, India
Nutritech Pharmaceuticals Private Limited₹40.2 Lakh (FY 2024)••••••••31.0%••••Delhi, India
Unirise Pharmaceuticals Private Limited₹40.2 Lakh (FY 2024)••••••••1.0%••••Lucknow, Uttar Pradesh, India
Steenbrass Pharmaceuticals Private Limited this company₹40.17 Lakh (FY 2015)••••••••-12.0%••••Mumbai, Maharashtra, India
Blazed Pharmaceuticals Private Limited₹40.08 Lakh (FY 2025)••••••••••••Bangalore, Karnataka, India
Armn Pharmaceutical India Private Limited₹40.08 Lakh (FY 2023)••••••••-1.0%••••Panipat, Haryana, India
Orziva Healthcare Private Limited₹40.07 Lakh (FY 2025)••••••••29.0%••••Chandigarh, India
Star Drugs & Research Labs Private Limited₹40.06 Lakh (FY 2020)••••••••-40.0%••••Housr, Tamil Nadu, India
Blissderma Pharmaceuticals Private Limited₹40.02 Lakh (FY 2025)••••••••39.0%••••Pune, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Steenbrass Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Charges & Borrowings of Steenbrass Pharmaceuticals Private Limited

Steenbrass Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Steenbrass Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Steenbrass Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Steenbrass Pharmaceuticals Private Limited

Steenbrass Pharmaceuticals Private Limited has 6 board changes on record since 2012: 4 appointments and 2 cessations. The latest: Ajay Kumar Kamala Prasad Tiwari ceased to be Additional Director on 30 Sep 2013.

AGM
Steenbrass Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records.
Filing
Steenbrass Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Mumbai.
Ceased
Ajay Kumar Kamala Prasad Tiwari ceased to be Additional Director.
Ceased
Suryaji Arjun Rane ceased to be Additional Director.
Appointed
Ajay Kumar Kamala Prasad Tiwari was appointed as Director.
Appointed
Suryaji Arjun Rane was appointed as Director.
Appointed
Deepchand Ramkhilavan Dubey was appointed as Director.
Appointed
Shailesh Sadanand Shukla was appointed as Director.
Incorporation
11 Oct 2012
Steenbrass Pharmaceuticals Private Limited was registered on 11 Oct 2012 with Roc Mumbai & aged 14 years 11 days as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Steenbrass Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Steenbrass Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Steenbrass Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Steenbrass Pharmaceuticals Private Limited

Steenbrass Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Steenbrass Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Steenbrass Pharmaceuticals Private Limited

Steenbrass Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Steenbrass Pharmaceuticals was a private limited company based in Mumbai, Maharashtra, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 11 October 2012 and is registered under CIN U74900MH2012PTC236693. The company has been struck off by the Registrar of Companies and is no longer operational.

Steenbrass Pharmaceuticals had 4 directors:

The CIN (Corporate Identification Number) of Steenbrass Pharmaceuticals is U74900MH2012PTC236693. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Steenbrass Pharmaceuticals is at Narayan Bldg 1st Flr Flat No.6 Parsiwadi Road Ghatkopar W, Mumbai, Maharashtra, India – 400086.

Steenbrass Pharmaceuticals was incorporated on 11 October 2012. It is registered with the Registrar of Companies, Mumbai.

Steenbrass Pharmaceuticals reported revenue of ₹40.17 Lakh for FY 2015 (down 12% YoY).

Steenbrass Pharmaceuticals has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh.

Steenbrass Pharmaceuticals reported a net loss of ₹2.23 Lakh (net margin -5.6%) and EBITDA of ₹2.7 Lakh (EBITDA margin 6.7%) for FY 2015, as per its filed financial statements.

No. Steenbrass Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.

Steenbrass Pharmaceuticals operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available